MedTrace Logo

Uqora Supplements in Women With UTIs

NCT04024046 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2022-09-27

No results posted yet for this study

Summary

This is a virtual study which will invite females over the age of 18 who have had 2 or more UTIs in the past 6 months to participate. The investigators are looking at the impact of a daily dietary supplement with the recurrence of UTIs. Participants will be blinded and randomized randomized into the Control Group or Groups 1 or 2. Control Group will receive a Placebo Drink-Mix and Placebo Capsules. Group 1 will receive the Uqora Drink-Mix and Placebo Capsules. Group 2 will receive the Uqora Drink-Mix and Uqora Capsules. Each group will receive 180 day supply of the products.

Conditions

Interventions

DIETARY_SUPPLEMENT

Uqora

Participants will receive 1 Placebo Drink-Mix and 2 Placebo Capsules Daily

DIETARY_SUPPLEMENT

Group1

Participants will receive 1 Uqora Drink-Mix and 2 Placebo Capsules Daily

DIETARY_SUPPLEMENT

Group 2

Participants will receive 1 Uqora Drink-Mix and 2 Uqora Capsules Daily

Sponsors & Collaborators

  • Uqora, Inc.

    collaborator UNKNOWN

  • Hawthorne Effect Inc.

    lead OTHER

Principal Investigators

  • Martina Speight, MSN, FNP-BC · Hawthorne Effect Inc.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-18
Primary Completion
2020-09-16
Completion
2020-09-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04024046 on ClinicalTrials.gov